Dr. Dipti Gupta, MD, MPH

Dr. Gupta practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.

Dr. Gupta's NPI, 1063623775, was assigned on May 24, 2007. Dr. Gupta holds New York license 268150.

Dr. Gupta's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.

Dr. Gupta's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. Dr. Gupta is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is Memorial Cardiopulmonary Group.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gupta practices, 2 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Gupta's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Gupta is licensed in New York.

CMS data shows 3,551 Medicare services from Dr. Gupta across 9 procedure codes in 2024, for 2,677 Medicare patients. Medicare paid $63,212 for them.

CMS counts 2,677 Medicare patients who saw Dr. Gupta in 2024. The largest group is 65 to 74, with 1,216 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 2.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gupta's median patient age at 67, with 52% women.

In 2024, Dr. Gupta wrote 205 Medicare Part D claims for 50 patients. 83% of them were for generic drugs. CMS names the drug for 111 of them, across 5 drugs with 11 or more claims each, at $22,560 in total drug cost. In 2023, CMS named 140 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Gupta for performance year 2024, reported as part of a group. Dr. Gupta accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gupta as offering telehealth.

Dmand AI links 68 papers to Dr. Gupta, published from 2012 to 2025. 2020 was the busiest year, with 12. The most frequent topics are Breast Neoplasms, Cardiovascular Diseases and Mammography. Dr. Gupta has published most often in AJR Am J Roentgenol. Dr. Gupta's most frequent co-authors are Sarju B. Ganatra, MD, Anju Nohria, MD and Justine V. Cohen, DO.

CMS Open Payments shows 6 general payments to Dr. Gupta from 4 drug and device companies from 2017 to 2024. Consulting fees make up the largest share, 92% of the total. Mitsubishi Tanabe Pharma America, Inc. paid the most, $3,850.